Small Pharma Valuation
| DMTTFDelisted Stock | USD 0.05 0.0009 1.80% |
Small Pharma seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of Small Pharma from inspecting the company fundamentals such as Shares Owned By Institutions of 3.00 %, return on equity of -0.78, and Shares Outstanding of 321.56 M as well as reviewing its technical indicators and probability of bankruptcy. . In general, most investors recommend locking in undervalued stocks and disposing overvalued stocks since, at some point, asset prices and their ongoing real values will draw towards each other.
Overvalued
Today
Please note that Small Pharma's price fluctuation is very steady at this time. Calculation of the real value of Small Pharma is based on 3 months time horizon. Increasing Small Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Small otc stock is determined by what a typical buyer is willing to pay for full or partial control of Small Pharma. Since Small Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Small OTC Stock. However, Small Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0509 | Real 0.0465 | Hype 0.05 | Naive 0.0443 |
The real value of Small OTC Stock, also known as its intrinsic value, is the underlying worth of Small Pharma OTC Stock, which is reflected in its stock price. It is based on Small Pharma's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Small Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Small Pharma helps investors to forecast how Small otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Small Pharma more accurately as focusing exclusively on Small Pharma's fundamentals will not take into account other important factors: Small Pharma Total Value Analysis
Small Pharma is currently anticipated to have takeover price of 24.67 M with market capitalization of 27.33 M, debt of , and cash on hands of 27.15 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Small Pharma fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
24.67 M | 27.33 M | 27.15 M |
Small Pharma Asset Utilization
One of the ways to look at asset utilization of Small is to check how much profit was generated for every dollar of assets it reports. Small Pharma has a negative utilization of assets of -0.41 %, losing $0.004124 for each dollar of assets held by the company. Inadequate asset utilization indicates the company is being less effective with each dollar of assets it has. In other words, asset utilization of Small Pharma shows how discouraging it operates for each dollar spent on its assets.Small Pharma Ownership Allocation
Small Pharma shows a total of 321.56 Million outstanding shares. Small Pharma maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Small Pharma Profitability Analysis
Net Loss for the year was (22.27 M) with profit before overhead, payroll, taxes, and interest of 45 K.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Small Pharma's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Small Pharma and how it compares across the competition.
About Small Pharma Valuation
The otc valuation mechanism determines Small Pharma's current worth on a weekly basis. Our valuation model uses a comparative analysis of Small Pharma. We calculate exposure to Small Pharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Small Pharma's related companies.Small Pharma Inc., a biotechnology company, focuses on developing short-acting psychedelics with therapy for the treatment of mental health conditions. The company was incorporated in 2015 and is headquartered in London, the United Kingdom. Small Pharma is traded on OTC Exchange in the United States.
8 Steps to conduct Small Pharma's Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Small Pharma's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Small Pharma's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Small Pharma's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Small Pharma's revenue streams: Identify Small Pharma's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Small Pharma's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Small Pharma's growth potential: Evaluate Small Pharma's management, business model, and growth potential.
- Determine Small Pharma's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Small Pharma's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Small Pharma Growth Indicators
Investing in growth stocks can be very risky. If the company such as Small Pharma does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 319.6 M | |
| Retained Earnings | -31.7 M |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Consideration for investing in Small OTC Stock
If you are still planning to invest in Small Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Small Pharma's history and understand the potential risks before investing.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |